Indomethacin And Ascorbate Inhibit Desmoid Tumors. [j Surg Oncol. 1980] - Pubmed Result
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Indomethacin And Ascorbate Inhibit Desmoid Tumors. [j Surg Oncol. 1980] - Pubmed Result as PDF for free.
More details
- Words: 442
- Pages: 1
A service of the U.S. National Library of Medicine and the National Institutes of Health
All Databases
Search
Nucleotide
PubMed
Limits Clear Display All: 1
PubMed
Preview/Index
Protein
Genome
Structure
OMIM
My NCBI [Sign In] [Register] PMC
Journals
Books
History
Clipboard
Advanced Search
Go
for Details
AbstractPlus
Show
20
Sort By
Send to
Review: 0 Links
1: J Surg Oncol. 1980;15(1):85-90. Related Articles
Indomethacin and ascorbate inhibit desmoid tumors.
Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. [D is Col on Rectum. 1992]
Waddell WR, Gerner RE. Administration of indomethacin caused complete resolution of a desmoid tumor after a partial response to radiation. In another patient, this drug caused an immediate response, then became ineffective. When large doses of ascorbic acid were given with indomethacin, slow resolution of the tumor began and has continued for 14 months. Treatment of a third case with indomethacin and ascorbic acid from the beginning produced shrinkage of the tumor which has continued to date. PMID: 7421272 [PubMed - indexed for MEDLINE]
Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. [Am JSurg. 1991] The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. [Cancer. 1987] Review Successful treatment of a desmoid tumor with doxorubicin. [Cancer. 1993] Review Combined administration of ethodolac, ascorbic acid and radiotherapy as adjuvant therapies in an extrathoracic desmoid tumor with gross [JBUON. 2006] » See Reviews...
|
» See All...
Cited by PubMed Central articles Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis. [BMC Cancer. 2002] Effects of sulindac on sporadic colorectal adenomatous polyps. [ Gut. 1997] Mesenteric mass in a 28-year-old woman. [Postg rad Me dJ. 1997] » See all (8)...
Patient Drug Information Ascorbic Acid (Cecon® Drops, Cenolate® , Cevi-Bid® , ...) Ascorbic acid is used to prevent and treat scurvy, a disease caused by a lack of vitamin C in the body. Indomethacin (Indocin® ) Indomethacin is used to relieve moderate to severe pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused ... Source: AHFS Consumer Medication Information
Recent Activity Turn Off
Clear
Indomethacin and ascorbate inhibit desmoid tumors. Inhibition of benzo(a)pyrene carcinogenesis in rats with vitamin C. Preventive action of vitamin C on nitrosamine formation. Prolongation of survival times of terminal cancer patients by administration of large dose... Vitamin C and cancer: an overview.
Display
AbstractPlus
Show
20
Sort By
Send to
Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer
All Databases
Search
Nucleotide
PubMed
Limits Clear Display All: 1
PubMed
Preview/Index
Protein
Genome
Structure
OMIM
My NCBI [Sign In] [Register] PMC
Journals
Books
History
Clipboard
Advanced Search
Go
for Details
AbstractPlus
Show
20
Sort By
Send to
Review: 0 Links
1: J Surg Oncol. 1980;15(1):85-90. Related Articles
Indomethacin and ascorbate inhibit desmoid tumors.
Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. [D is Col on Rectum. 1992]
Waddell WR, Gerner RE. Administration of indomethacin caused complete resolution of a desmoid tumor after a partial response to radiation. In another patient, this drug caused an immediate response, then became ineffective. When large doses of ascorbic acid were given with indomethacin, slow resolution of the tumor began and has continued for 14 months. Treatment of a third case with indomethacin and ascorbic acid from the beginning produced shrinkage of the tumor which has continued to date. PMID: 7421272 [PubMed - indexed for MEDLINE]
Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. [Am JSurg. 1991] The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. [Cancer. 1987] Review Successful treatment of a desmoid tumor with doxorubicin. [Cancer. 1993] Review Combined administration of ethodolac, ascorbic acid and radiotherapy as adjuvant therapies in an extrathoracic desmoid tumor with gross [JBUON. 2006] » See Reviews...
|
» See All...
Cited by PubMed Central articles Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis. [BMC Cancer. 2002] Effects of sulindac on sporadic colorectal adenomatous polyps. [ Gut. 1997] Mesenteric mass in a 28-year-old woman. [Postg rad Me dJ. 1997] » See all (8)...
Patient Drug Information Ascorbic Acid (Cecon® Drops, Cenolate® , Cevi-Bid® , ...) Ascorbic acid is used to prevent and treat scurvy, a disease caused by a lack of vitamin C in the body. Indomethacin (Indocin® ) Indomethacin is used to relieve moderate to severe pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused ... Source: AHFS Consumer Medication Information
Recent Activity Turn Off
Clear
Indomethacin and ascorbate inhibit desmoid tumors. Inhibition of benzo(a)pyrene carcinogenesis in rats with vitamin C. Preventive action of vitamin C on nitrosamine formation. Prolongation of survival times of terminal cancer patients by administration of large dose... Vitamin C and cancer: an overview.
Display
AbstractPlus
Show
20
Sort By
Send to
Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer
